Literature DB >> 18520643

Effects of chronic sepsis on contractile properties of fast twitch muscle in an experimental model of critical illness neuromyopathy in the rat.

Benoit Rossignol1, Gildas Gueret, Jean-Pierre Pennec, Julie Morel, Fabrice Rannou, Marie-Agnès Giroux-Metges, Hélène Talarmin, Maxime Gioux, Charles C Arvieux.   

Abstract

OBJECTIVE: Critical illness polyneuromyopathy has been extensively studied in various animal models regarding electrophysiological aspects or molecular mechanisms involved in its physiopathology; however, little data are available on its main clinical feature, that is, muscular weakness. We have studied the effects of chronic sepsis in rats with special consideration to contractile and neuromuscular blockade properties in relation with the level of messenger RNA (mRNA) coding for ryanodine and acetylcholine receptors.
DESIGN: This was an experimental animal study.
SETTING: This study was conducted at a university laboratory.
SUBJECTS: Subjects consisted of Wistar rats.
INTERVENTIONS: Chronic sepsis was achieved by cecal ligation and needle perforation. Ten days after surgery, fast twitch extensor digitorum longus was excised for extraction and assays of mRNA coding for ryanodine and acetylcholine receptor subunits and contralateral muscle was tested in vivo on a mechanical bench. A fatigability index was measured and neuromuscular blockade properties using atracurium were evaluated.
MEASUREMENTS AND MAIN RESULTS: A decrease in active force developed by extensor digitorum longus associated with an increase in passive force is induced by chronic sepsis. Maximal force at optimal length during twitch contraction was significantly reduced (0.25 +/- 0.09 N vs. 0.17 +/- 0.06 N); contraction and relaxation speeds were higher as shown by the decrease of respective time constants (3.75 +/- 0.01 msec vs. 2.70 +/- 0.0 msec, 10.76 +/- 0.03 msec vs. 7.62 +/- 0.03 msec) in the control group compared with the septic group. Fatigability index was significantly lower (23 +/- 0.11% vs. 59 +/- 0.19%) in septic rats. These rats also showed quicker blockade and shorter recovery after atracurium administration. Sepsis induced a significant increase of the expression of ryanodine receptor (RyR) RyR1 along with a steady expression of RyR3 mRNA, leading to a 5.6-fold increase of RyR1/RyR3 ratio with a steadiness of mRNA corresponding to acetylcholine-receptors.
CONCLUSIONS: Chronic inflammation and sepsis induced a decrease in contractile performances of extensor digitorum longus along with accelerated kinetics of atracurium possibly induced by modified expression of RyR1 receptors and not acetylcholine-receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18520643     DOI: 10.1097/CCM.0b013e318176106b

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  19 in total

1.  Sodium channel Na(V)1.5 expression is enhanced in cultured adult rat skeletal muscle fibers.

Authors:  J Morel; F Rannou; H Talarmin; M A Giroux-Metges; J P Pennec; G Dorange; G Gueret
Journal:  J Membr Biol       Date:  2010-06-02       Impact factor: 1.843

Review 2.  [Intensive care unit-acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy].

Authors:  K Judemann; D Lunz; Y A Zausig; B M Graf; W Zink
Journal:  Anaesthesist       Date:  2011-10       Impact factor: 1.041

3.  IL-1α reversibly inhibits skeletal muscle ryanodine receptor. a novel mechanism for critical illness myopathy?

Authors:  Oliver Friedrich; Bing Yi; Joshua N Edwards; Barbara Reischl; Anette Wirth-Hücking; Andreas Buttgereit; Roland Lang; Cornelia Weber; Fabian Polyak; Ilon Liu; Frederic von Wegner; Tanya R Cully; Aven Lee; Patrick Most; Mirko Völkers
Journal:  Am J Respir Cell Mol Biol       Date:  2014-06       Impact factor: 6.914

4.  Polarization-resolved second harmonic microscopy of skeletal muscle in sepsis.

Authors:  Matthieu Dubreuil; Florine Tissier; Lucas Le Roy; Jean-Pierre Pennec; Sylvain Rivet; Marie-Agnès Giroux-Metges; Yann Le Grand
Journal:  Biomed Opt Express       Date:  2018-11-19       Impact factor: 3.732

5.  The diaphragm is better protected from oxidative stress than hindlimb skeletal muscle during CLP-induced sepsis.

Authors:  Hélène Talarmin; Frédéric Derbré; Luz Lefeuvre-Orfila; Karelle Léon; Mickaël Droguet; Jean-Pierre Pennec; Marie-Agnès Giroux-Metgès
Journal:  Redox Rep       Date:  2016-09-06       Impact factor: 4.412

6.  Use of Organ Dysfunction as a Primary Outcome Variable Following Cecal Ligation and Puncture: Recommendations for Future Studies.

Authors:  Mabel N Abraham; Alexander P Kelly; Ariel B Brandwein; Tiago D Fernandes; Daniel E Leisman; Matthew D Taylor; Mariana R Brewer; Christine A Capone; Clifford S Deutschman
Journal:  Shock       Date:  2020-08       Impact factor: 3.454

Review 7.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

8.  Loss of muscle strength during sepsis is in part regulated by glucocorticoids and is associated with reduced muscle fiber stiffness.

Authors:  Nima Alamdari; Gianluca Toraldo; Zaira Aversa; Ira Smith; Estibaliz Castillero; Guillaume Renaud; Rizwan Qaisar; Lars Larsson; Ravi Jasuja; Per-Olof Hasselgren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-09-26       Impact factor: 3.619

9.  Enhanced muscle shortening and impaired Ca2+ channel function in an acute septic myopathy model.

Authors:  Oliver Friedrich; Ernst Hund; Frederic von Wegner
Journal:  J Neurol       Date:  2009-11-04       Impact factor: 4.849

10.  Trauma, systemic inflammatory response syndrome, dietary supplements, illicit steroid use and a questionable malignant hyperthermia reaction.

Authors:  John F Capacchione; Matthew C Radimer; Jeffrey S Sagel; Gregory P Kraus; Nyamkhishig Sambuughin; Sheila M Muldoon
Journal:  Anesth Analg       Date:  2009-03       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.